Randomized, Double Blind Evaluation of Sequential Administration of gp120 B/E (AIDSVAX B/E) (GSID) With 1-Year Boosting in HIV-uninfected Thai Adults
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 20 Sep 2019
Price : $35 *
At a glance
- Drugs HIV gp120 vaccine (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics
- 18 Sep 2019 Planned End Date changed from 1 Dec 2019 to 1 May 2020.
- 31 Aug 2018 Biomarkers information updated
- 14 Aug 2018 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.